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Purpose: Mentally disabled patients show different recovery profiles compared to 
normal patients after general anesthesia. However, the relationship of dose-recovery 
profiles of mentally disabled patients has never been compared to that of normal pa-
tients. Materials and Methods: Twenty patients (10 mentally disabled patients and 
10 mentally intact patients) scheduled to dental surgery under general anesthesia was 
recruited. Sevoflurane was administered to maintain anesthesia during dental treat-
ment. At the end of the surgery, sevoflurane was discontinued. End-tidal sevoflurane 
and recovery of consciousness (ROC) were recorded after sevoflurane discontinua-
tion. The pharmacodynamic relation between the probability of ROC and end-tidal 
sevoflurane concentration was analyzed using NONMEM software (version VII). 
Results: End-tidal sevoflurane concentration associated with 50% probability of 
ROC (C50) and γ value were lower in the mentally disabled patients (C50=0.37 vol %, 
γ=16.5 in mentally intact patients, C50=0.19 vol %, γ=4.58 in mentally disabled pa-
tients). Mentality was a significant covariate of C50 for ROC and γ value to pharma-
codynamic model. Conclusion: A sigmoid Emanx model explains the pharmacody-
namic relationship between end-tidal sevoflurane concentration and ROC. Mentally 
disabled patients may recover slower from anesthesia at lower sevoflurane concen-
tration at ROC an compared to normal patients.
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INTRODUCTION
When anesthetizing patients, achieving a precise return of consciousness (ROC) after 
anesthesia is an important component for successful anesthesia no less than inducing 
rapid and safe anesthesia.1 Recently, ambulatory anesthesia has been increasingly 
used to tailor the need of rapid discharge after an outpatient’s procedure which is 
Original Article http://dx.doi.org/10.3349/ymj.2014.55.6.1624pISSN: 0513-5796, eISSN: 1976-2437          Yonsei Med J 55(6):1624-1630, 2014
Recovery Profiles in Mentally Disabled Patients
Yonsei Med J   http://www.eymj.org   Volume 55   Number 6   November 2014 1625
ered stop crying as a behavior of LOC during sevoflurane 
administration. After achieving LOC, assisted ventilation 
was attempted until they stopped to breathe spontaneously. 
After intravenous cannulation, vecuronium at a dose of 0.1 
mg/kg was administered as a neuromuscular blockade. Af-
ter confirming complete neuromuscular blockade, nasotra-
cheal intubation was performed. Next, dental treatments 
were performed under general anesthesia at the discretion 
of the dentists. Age adjusted 1 minimum alveolar concentra-
tion (MAC) sevoflurane was administered combined with 
50% nitrous oxide during dental procedures.6 All efforts 
were made to maintain normothermia during dental proce-
dures. After the treatments, sevoflurane administration was 
stopped. Neuromuscular blockade was reversed with the 
dosages selected depending on their weight of glycopyrro-
late (0.01 mg/kg up to 40 kg, 0.4 mg over 40 kg) and pyr-
idostigmine (0.25 mg/kg up to 40 kg, 15 mg over 40 kg). We 
controlled and assisted their respiration with 100% oxygen 
with a flow of 6 L/min to keep the end-tidal carbon dioxide 
in the range of 30‒35 mm Hg for maintaining the condition 
of ventilation consistently as much as possible during emer-
gence from sevoflurane anesthesia. ROC from anesthesia 
was defined as the recovery of the observer’s assessment of 
awareness/sedation (OAA/S) score 3 defined as the response 
of after name is called loudly or repeatedly.7 At the end of 
surgery and at ROC, Etsevo was continuously recorded with 
a software (Datex-Ohmeda S5TM Collect; GE Healthcare, 
Helshinki, Finland) and ROC was observed by an investiga-
tor every 15 seconds. The patients were extubated when they 
gained consciousness to the pre-anesthesia level from sevo-
flurane anesthesia and achieved the reversal of neuromuscu-
lar blockade assessed using a peripheral nerve stimulator. 
The recovery of neuromuscular blockade was evaluated as 
the train of four count or clinical signs (ex. head elevation, 
leg elevation, the return of adequate tidal volume). The dura-
tions of sevoflurane administration, anesthesia, and dental 
treatment were recorded. We also recorded hemodynamic 
variables [systolic, diastolic, and mean blood pressure (BP)] 
from anesthesia record. The observed ROC was recorded as 
0 for unconscious state or 1 for conscious state. A sigmoidal 
Emax model as described below was used to derive the rela-
tionship between Etsevo and the probability of ROC: 
P=1-
     Cγ
         C50γ+Cγ
where P indicates the probability of ROC from anesthe-
sia, C is the Etsevo, C50 is the Etsevo associated with 50% 
probability of ROC, and γ is the steepness of the Etsevo-re-
simple and can be done for a short time. Rapid and safe re-
covery from anesthesia is necessary for successful treat-
ment in the ambulatory setting. In dental practice, mentally 
disabled patients are subject to general anesthesia for dental 
treatment because of their poor cooperability.2-4 They seem 
to show different recovery profiles compared to normal pa-
tients in our experiences. However, without information on 
the pharmacodynamic features of mentally disabled pa-
tients, we cannot compare inhaled anesthetic concentrations 
during emergence precisely compared to normal patients. 
Therefore, population pharmacodynamics modeling incor-
porating mental difference as a covariate could be clinically 
useful for investigating the difference of emergence after 
general anesthesia. 
We aimed to investigate the relationship between end-tid-
al sevoflurane concentration (Etsevo) and ROC in both nor-
mal pediatric patients and mentally disabled patients under-
going general anesthesia with sevoflurane and to identify 
the covariates (especially mental ability) in the pharmaco-
dynamic relationship between Etsevo and ROC.
MATERIALS AND METHODS
Subjects
We enrolled pediatric patients aged 3 to 15 years old sched-
uled for dental treatment under general anesthesia in the 
study. Among them, we included patients diagnosed with se-
vere mental disability in the department of pediatrics and 
American Society of Anesthesiologists (ASA) class 1 pa-
tients with intact mental ability into the study. The other ex-
clusion criteria were as follows: those who have history or 
adverse reaction to anesthetic medication, those who have 
cardiac, pulmonary, hepatic or renal disease. The study was 
approved by the Institutional Review Board of the Seoul Na-
tional University Dental College (S-D20121007). The study 
was exempt from informed consent by the ethics committee 
since the study protocol was a routine part of general anes-
thesia.
 
Anesthesia protocols
All patients received the same anesthesia protocols. After 
being transferred to a dental chair, they were connected to a 
breathing circuit through a tightly sealed facial mask. Sevo-
flurane at a concentration of 8 vol % was administered with 
a flow of 6 L/min. We defined loss of consciousness (LOC) 
as loss of the response to verbal command.5 We also consid-
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OFV calculated from the randomization test and the origi-
nal OFV was more than 3.84.
RESULTS
 
Twenty patients that met the inclusion criteria were enrolled 
into the study. Among them, 10 patients were mentally dis-
abled persons. They were severely mental retarded with the 
impairment of daily living activities irrespective of their pri-
mary causes of neurologic disturbances. All patients under-
went restorative treatment for dental caries under volatile an-
esthetics induction and maintenance anesthesia with 
sevoflurane. Table 1 shows their demographic characteristics, 
the duration of dental procedures and sevoflurane anesthesia, 
which were not significantly different between two groups. 
Hemodynamic variables (systolic, diastolic, and mean BP) 
were not significantly different between the two groups (data 
not shown).
A total of 476 measurements were used to build a pharma-
codynamic model. Table 2 lists the estimated model parame-
ter of the basic and final model. To investigate whether men-
tality have a significant effect on C50 value at ROC, this was 
included as a covariate in C50. This inclusion significantly de-
creased the minimum value of the objective function from 
207.7 to 185.8. We also included mentality as a covariate in 
γ. This inclusion significantly improved the performance of 
model, mentality included in C50 as a covariate. The mini-
mum value of OFV was decreased from 185.8 to 165.1 by 
more than 3.84 (p<0.05). The difference between the median 
OFV calculated from the randomization test and the original 
OFV was more than 3.84 (the original OFV=165.1, the me-
dian OFV after randomization test=205.6), confirming that 
mentality is a significant covariate. Other covariates includ-
ing age, sex, height, weight, anesthetic time, and dental pro-
cedure time did not improve the performance of the selected 
model significantly. Table 2 lists the estimated model param-
eter of the finally selected pharmacodynamic model and 
sponse curve.
Statistical analysis
As previously reported,7 we estimated the population base 
model parameters with the use of the option “LIKELIHOOD 
LAPLACE METHOD=conditional” incorporated in the 
Nonlinear Mixed Effects Modeling (NONMEM) software 
(version VII; GloboMax, Hanover, MD, USA). The inter-
individual random variability of C50 and γ was estimated 
using an exponential error model (Appendix 1). The popu-
lation model parameters were derived from NONMEM anal-
ysis where the objective function value, a statistic proportion-
al to negative twice the log likelihood of the data, was the 
lowest. After obtaining the population base model, a for-
ward inclusion and backward elimination approach was 
used in consecutive NONMEM runs to find out the relevant 
covariates among the covariates (age, sex, height, weight, 
anesthetic time, and dental procedure time) as previously 
described.8 The difference in the minimum value of the ob-
jective function between two nested models approximately 
follows a chi square-distribution and could therefore be 
used to investigate statistical significance [chi square statis-
tics equals to 3.84 at the level of significance (p<0.05) with 
one degree of freedom]. A non-parametric bootstrap proce-
dure was performed for internal validation using Perl-
speaks-NONMEM (PsN) (version 3.6.2, http://psn.source-
forge.net). In brief, the original data set was randomly 
sampled to generate 2000 bootstrap replicates. We obtained 
the 95% confidence interval of the nonparametric bootstrap 
replicates and compared final model parameter estimates 
with them. Also we performed a randomization test to test 
whether the selected covariate is a significant one using 
Wings for NONMEM (version 7.2, http://wfn.source-
fourge.net). We randomly permuted a significant covariate 
in the original data set 1000 times. We calculated the objec-
tive function value (OFV) of the model without the covari-
ate parameter relationship. We considered the covariate as a 
significant one when the difference between the median 
Table 1. Demographic Variables 
Clinical variables Normal group (n=10) Mentally disabled group (n=10)  p value
Sex (male/female) 5/5 6/4 0.65
Age (yrs)     6 (2‒8)     6 (2‒12) 0.32
Height (cm) 107 (87.8‒135) 101 (85‒120) 0.15
Weight (kg)   22 (9.9‒35)   15 (9.5‒33) 0.06
Duration of sevoflurane anesthesia time (mins)   70 (60‒155) 120 (90‒230) 0.08
Duration of dental treatment (mins)   60 (50‒145)   95 (75‒210) 0.16
Data are expressed in median (range). Range indicates the minimal and maximal value, respectively.  
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The C50 for ROC in this study is equivalent to MAC-
awake value previously reported. According to our results, 
the typical C50 value of Etsevo for ROC in normal pediatric 
patients was 0.37 vol %, which was considered as a low 
value of C50 for ROC because MAC-awake value of sevo-
flurane was 0.6‒0.67 vol % for healthy adults11-13 and 0.78 
vol % for healthy children,14 respectively. It is unclear why 
our value of C50 is lower than MAC-awake value reported 
in the previous reports, but this difference may be attributed 
to the difference of methodological approach to calculate 
C50 value. In this study, we collected dissipating Etsevo rath-
er than stable Etsevo during emergence, which could repre-
sent sevoflurane concentration in brain, described in Kihara, 
et al.14 The observed Etsevo would be lower than actual 
brain tissue concentration of sevoflurane due to hysteresis 
phenomenon during decreasing phase of sevoflurane con-
centration. However, our results may be more applicable in 
clinical practice because stepwise decrement of sevoflurane 
administration is rarely used during emergence.
bootstrap estimates. The relationship between the probability 
of ROC and Etsevo are plotted in Fig. 1. We also simulated 
the effect of mental ability on the relationship between Etse-
vo and the probability of ROC using the final population pa-
rameters. The selected C50 and γ value in normal and men-
tally disabled patients upon computer simulation were the 
final model parameters. The pharmacodynamic relationship 
between Etsevo and the probability of ROC in accordance 
with mental ability using the final population parameters are 
presented in Fig. 1. 
DISCUSSION
In this study, we found that mentality can influence ROC dur-
ing emergence from sevoflurane anesthesia. Also, preopera-
tive mental ability was proved to be a significant factor influ-
encing γ as well as C50 in the quantitative relationship between 
Etsevo and ROC. To our best knowledge, this is the first clini-
cal study to investigate the dose‒ROC relationship during 
emergence from anesthesia based on pharmacodynamic mod-
eling with the inclusion of mental ability as a covariate. 
In clinical practice, it can be advantageous to apply the 
predicted Etsevo for ROC in mentally disabled patients rath-
er than a population-based average Etsevo value. In this 
study, large inter-individual variability of Etsevo for ROC 
could be explained by incorporating the mental ability as a 
covariate in nonlinear sigmoid Emax model. A non-linear 
sigmoidal Emax model has an advantage over other statisti-
cal approaches in estimating the quantal response.9,10 Not 
only the C50 value but the steepness of the concentration-ef-
fect relationship (γ) can be estimated from this method, 
which can make the selection of significant covariates easier 
in comparison to logistic regression. And we can predict the 
response of ROC at a certain Etsevo more accurately using 
non-linear regression analysis.
Table 2. The Estimated Pharmacodynamic Parameters 
Model Covariate Parameter Estimate (% RSE) Median (2.5‒97.5%) CV (%) OFV
Basic - C50 (vol %) 0.28 (9.3) - 36.19 207.7
- γ 7.79 (21.2) -
Final Mentality
    Intact C50 (vol %) 0.37 (3.5) 0.37 (0.34‒0.39) 12.28 165.09
γ 16.4 (19.0) 16.4 (13.7‒23.7)
    Disabled C50 (vol %) 0.19 (12.5) 0.19 (0.14‒0.24)
γ 4.53 (22.3) 4.56 (3.0‒8.1)
RSE, relative standard error; CV, coefficients of variation; OFV, minimum value of objective function; C50, end-tidal sevoflurane concentration associated 
with 50% probability of return of consciousness; γ, steepness of the concentration-response curve.  
Bootstrap analysis were repeatedly performed 2000 times. 
Fig. 1. The relationship between end-tidal sevoflurane concentration and 
probability of return of consciousness. The red scattered lines indicate indi-
vidual fits for mentally disabled patients. The black solid lines indicate indi-
vidual fits for mentally intact patients. The red thick scattered line denotes 
the representative of fit for mentally disabled patient. The black thick solid 
line denotes the representative of fit for mentally intact patient. Etsevo, end-
tidal sevoflurane concentration; ROC, recovery of consciousness.
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eral anesthesia. Most of dental treatment under general an-
esthesia has been performed in the ambulatory setting. In 
this sense, prolonged recovery from anesthesia can be a sig-
nificant obstacle in performing ambulatory anesthesia for 
safety of mentally disabled patients. Therefore, it is of ut-
most importance to maintain an adequate level of anesthe-
sia during dental treatment to prevent prolonging recovery 
and to facilitate the patient’s recovery. 
However, our study has some limitations. We regarded 
the recovery of OAA/S score 3 as ROC from anesthesia. 
There might be some bias in the observation of ROC during 
emergence since mentally disabled patients responded to the 
stimuli less promptly. However, neurophysiologic surrogate 
for consciousness in mentally disable pediatrics has not been 
properly evaluated. And this method such OAA/S score is 
still clinically acceptable during emergence from general an-
esthesia. In this study, we measured rapidly decreasing Etse-
vo rather than stable Etsevo during emergence. Therefore, 
the measured Etsevo may not reflect effect site concentra-
tion of sevoflurane due to hysteresis phenomenon. Although 
stepwise decrement of sevoflurane during the time long 
enough to allow the equilibrium of sevoflurane between the 
blood and the brain is rarely used during emergence, this ad-
ministration technique makes it possible to evaluate the ef-
fect of mentality on pharmacodynamic relationship be-
tween the actual brain sevoflurane concentration and ROC. 
A further study should be needed to investigate whether 
mentally disabled patients recover from anesthesia at lower 
effect-site sevoflurane concentration. 
In conclusion, mentality of patients significantly affects the 
pharmacodynamic relationship between Etsevo and ROC. 
Mentally disabled patients may have different recovery pro-
files reflected by lower sevoflurane concentration at ROC 
and γ value compared to normal patients. Clinicians should 
be cautious about the possibility of delayed recovery from 
general anesthesia for mentally disabled patients. 
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APPENDIX 1
NONMEM control code
$PROB RUN# 20009
$DATA MAC-awake2.csv IGNORE=@ 
$INPUT ID TIME DOSE R=DV MEN AGE HT WT SDUR ADUR
$PRED
    CE50=(THETA(1)*(1-MEN)+THETA(2)*MEN)*EXP(ETA(1))
    GAM=(THETA(3)*(1-MEN)+THETA(4)*MEN) * EXP(ETA(2))
  
    PROB=1-DOSE**GAM/(CE50**GAM+DOSE**GAM)
    Y=R*PROB+(1-R)*(1-PROB)
  
    IPRED=Y
    W=1
    IRES=DV-IPRED
    IWRES=IRES     
$THETA
    (0, 0.4); CE50-1
    (0, 0.2); CE50
    (0, 11); GAM
    (0, 6); GAM-1
$OMEGA 
    0.1; [P]
    0 FIX
$ESTIMATION LIKELIHOOD LAPLACE MAX=3000 PRINT=1 NOABORT METHOD=1 SIG=3
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$COVARIANCE PRINT=E
$TABLE ID ETA(1) ETA(2) 
       FILE=20009.ETA NOPRINT ONEHEADER FIRSTONLY NOAPPEND
$TABLE ID CE50 GAM 
       FILE=20009.PAR NOPRINT ONEHEADER NOAPPEND
$TABLE ID DOSE R PROB Y IPRED IRES RES IWRES 
       FILE=sdtab20009 NOPRINT ONEHEADER 
$TABLE ID CE50 GAM ETA(1) ETA(2) 
       FILE=patab20009 NOPRINT ONEHEADER NOAPPEND
